Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sanofi (GB:0O59)
LSE:0O59
Sanofi (0O59) Share Price & Analysis
8 Followers
0O59 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€77.73 - €104.70
Previous Close€96.4
Volume224.97K
Average Volume (3M)1.87M
Market Cap
€122.03B
Enterprise Value€130.98B
Total Cash (Recent Filing)€8.71B
Total Debt (Recent Filing)€18.15B
Price to Earnings (P/E)28.6
Beta0.49
Next Earnings
Oct 25, 2024EPS Estimate
€2.53Last Dividend Ex-Date
May 13, 2024Dividend Yield3.85%
Share Statistics
EPS (TTM)3.37
Shares Outstanding1,264,803,301
10 Day Avg. Volume382,648
30 Day Avg. Volume1,872,936
Standard Deviation0.05
R-Squared0.16
Alpha0.00248
Financial Highlights & Ratios
Price to Book (P/B)40.36
Price to Sales (P/S)2.13
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€105.92Price Target Upside9.87% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
Sanofi News
PremiumPre-Earnings
Is SNYNF a Buy, Before Earnings?
Bulls Say, Bears Say
Bulls Say
Financial PerformanceSanofi's net debt to total capital is at 5%, indicating strong financial health.
Growth DriversDupixent's strong performance with a 22% increase continues to be a key growth driver.
Strategic DevelopmentsBeyfortus could easily help Sanofi exceed the €10bn revenue mark by 2030, making it a game-changer for the company.
Bears Say
Financial PerformanceCore operating income came to €2.8bn (-15%), 2% above consensus despite higher-than-expected COGS and lower capital gains.
Legal IssuesAbout 75,000 suits filed in state after federal cases tossed.
Market CompetitionAubagio (-68%) due to generic competition.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
12.69% Mutual Funds
15.04% Other Institutional Investors
72.27% Public Companies and
Individual Investors
0O59 FAQ
What was Sanofi’s price range in the past 12 months?
Sanofi lowest share price was €77.73 and its highest was €104.70 in the past 12 months.
What is Sanofi’s market cap?
Currently, no data Available
When is Sanofi’s upcoming earnings report date?
Sanofi’s upcoming earnings report date is Oct 25, 2024 which is in 90 days.
How were Sanofi’s earnings last quarter?
Sanofi released its earnings results on Jul 25, 2024. The company reported €1.73 earnings per share for the quarter, beating the consensus estimate of €1.649 by €0.081.
Is Sanofi overvalued?
According to Wall Street analysts Sanofi’s price is currently Undervalued.
Does Sanofi pay dividends?
Sanofi pays a Annually dividend of €3.76 which represents an annual dividend yield of 3.85%. See more information on Sanofi dividends here
What is Sanofi’s EPS estimate?
Sanofi’s EPS estimate is €2.53.
How many shares outstanding does Sanofi have?
Sanofi has 1,268,607,200 shares outstanding.
What happened to Sanofi’s price movement after its last earnings report?
Sanofi reported an EPS of €1.73 in its last earnings report, beating expectations of €1.649. Following the earnings report the stock price went down -15.666%.
Which hedge fund is a major shareholder of Sanofi?
Currently, no hedge funds are holding shares in GB:0O59
---
Sanofi Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€105.92 (9.87% Upside)
€105.92 (9.87% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-1.30%
12-Months-Change
Fundamentals
Return on Equity
5.80%
Trailing 12-Months
Asset Growth
1.69%
Trailing 12-Months
Company Description
Sanofi
Sanofi engages in the research, production and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Human Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes & cardiovascular, established prescription products and generics, together with research, development and production activities. This segment also includes all associates whose activities are related to pharmaceuticals. The Consumer Healthcare segment comprises, for all geographical territories, the commercial operations for its Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development and production activities dedicated to vaccines. The company was founded in 1973 and is headquartered in Paris, France.
---
0O59 Company Deck
---
0O59 Earnings Call
Q2 2024
0:00 / 0:00
---
0O59 Stock 12 Month Forecast
Average Price Target
€105.92
▲(9.87% Upside)
Technical Analysis
Best Analysts Covering 0O59
1 Year
1 Year Success Rate
14/18 ratings generated profit
1 Year Average Return
+5.90%
reiterated a buy rating 12 months ago
Copying Dominic Lunn's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +5.90% per trade.
---